Why I Am Passing On BrainsWay And Neuronetics (Archive)
Passing on deep-value BrainsWay and market-leader Neuronetics for superior Nexstim exposure.
This 5-Minute Pitch was originally published on Seeking Alpha before the launch of the Hunting Alphas website. It is shared here to showcase my previous work and track record. New 5-Minute Pitches published on this site will not be disseminated anywhere else.
Elevator Pitch
- I am bullish on the niche industry that uses magnetic stimulation for brain therapies.
- BrainsWay and Neuronetics are US-listed stocks in this niche, however they are highly unprofitable with volatile sales growth.
- BrainsWay is a deep value stock with cash in excess of its enterprise value, but without a catalyst in the horizon to unlock.
- Nexstim is a growth leader and the only profitable player, trading at only a 11% premium to Neuronetics, which is the market leader.
- Overall, whilst I like BrainsWay and Neuronetics, Nexstim is my preferred option to play the magnetic waves.
Read the full article here.
Disclosures and Disclaimers
Past performance ≠ future results. Not investment advice. See full Disclaimer.
Comments ()